期刊文献+

14例乳腺神经内分泌癌病理及临床分析 被引量:1

下载PDF
导出
摘要 目的:探讨乳腺神经内分泌癌的临床病理特点,并进行随访,观察预后。方法:观察14例乳腺神经内分泌癌的组织学特征并进行免疫组织化学染色分析。结果:本组患者均为女性,年龄32~72岁,平均57.3岁,均行乳腺癌根治术,术后随访3~58个月,均存活,进行神经内分泌标记均为阳性。结论:乳腺神经内分泌癌预后较好,CerbB2基因、Ki67可能是乳腺神经内分泌癌的预后指标之一。
机构地区 山西省人民医院
出处 《亚太传统医药》 2011年第8期144-145,共2页 Asia-Pacific Traditional Medicine
基金 山西省人民医院科研项目(2009043)
  • 相关文献

参考文献6

  • 1UPALAKAI.IN J, COLLINS L, TAWA N, et al. Carcinoid tumors in the breast[J]. Am J Surg,2006,191(6) :422,799-805.
  • 2TAVASSOLI F,DEVILE P. WHO classification of tumours, pathology and genetics of the breast and female organs[M]. Lyon: IARC Press, 2003 : 32-34.
  • 3SAPINO A, RIGHI L, C ASSONI P, et al. Expression of the neu2 roendocrine phenotype in carcinomas of the breast[J]. Semin Diagn Pathol,2000 (17) :127-137.
  • 4程虹,戴林,沈丹华,等.乳腺及女性生殖器官肿瘤,病理学和遗传学[M].北京:人民卫生出版社,2006:30.
  • 5ZEKIOGLU O, ERHAN Y, CIRIS M, et al. Neuroendocrine differentiated carcinomas of the breast: a distinct entity[J]. Breast,2003,12(4) :251-257.
  • 6LEE WS, LEE J E, KIM J H,et al. Analysis of prognostic factors and treatment modality changes in breast cancer:a single institution study in Korea[J]. Yonsei Med J, 2007,8 (3) :465-473.

同被引文献14

  • 1Gunhan - Bilgen I, Zekioglu 0, Ustun EE, et al , Neuroendocrine differentiated breast carcinoma: imaging features correlated with clinical and histopathological findings. Eur Radiol, 2003 , 13 ( 4 ) : 788-793.
  • 2Sobin LH, Gospodarowiez MK, Wittekind C.TNM classification of malignant tumors. 7th ed.Hoboken: John Wiley& Sons, 2009.
  • 3Tavassoli FA ,Devile P. WHO classification oftumours,pathology and genetics of the breast and female organs.Lyon: IARC Press, 2003: 32-34.
  • 4Sapino A, Righi L, Cassoni P, et al.Expression of the neuroendocrine phenotype in carcinomas of the breast.Semin Diagn Pathol, 2000, 17(2): 127-137.
  • 5Iwase H, Ando Y, Ichihara S, et al. Immunhistochemieal analysis on biological makers in ductal carcinoma in situ of the breast. Cancer , 2001,8(2):98-104.
  • 6Chen H, Pimienta G, Gu Y, et al.Proteomic characterization of Her21 neu -overexpressing breast cancer cells. Proteomics, 2010,10(21): 3800-3810.
  • 7Sivridis E, Stamos C, Fiska A, et al.CerbB-2 and the "triple-state" in early breast carcinomas. Med Oncol, 2010, 27( 3): 578-584.
  • 8Chen XS,Ma CD,Wu JY.et al.Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.Tumori, 2010, 96( 1) : 103-110.
  • 9Zekioglu O,Erhan Y,Ciris M,et al.Neuroendocrine differentiated carcinoma of the breast: a distinct entity.Breast, 2003, 12( 4 ) : 251-257.
  • 10Tian Z , Wei B, Tang F, et al.Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol,2011 ,42(8): 1169 -1177.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部